{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:49:53Z","timestamp":1790009393876,"version":"4.0.1"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","award":["2020-3735"],"award-info":[{"award-number":["2020-3735"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The prevalence of refractory Mycoplasma pneumoniae (MP) pneumonia is increasing. The present study aimed to identify the predictive factors of responses to treatment of MP pneumonia in children. A total of 149 children were diagnosed with MP pneumonia, of whom 56 were included in the good response group, 75 children in the slow response group, and 18 children in no response or progression group. Data on the clinical, laboratory, and radiologic features were retrospectively obtained through medical chart reviews. The severity of pneumonia, based on the extent of pneumonic lesions on chest x-ray (adjusted odds ratio (aOR), 10.573; 95% confidence intervals (CIs), 2.303\u221248.543), and lactate dehydrogenase (LDH) levels (aOR, 1.002; 95% CIs, 1.000\u20131.004) at the time of admission were associated with slow response to treatment of MP pneumonia. Pleural effusion (aOR, 5.127; 95% CIs, 1.404\u201318.727), respiratory virus co-infection (aOR, 4.354; 95% CIs, 1.374\u201313.800), and higher LDH levels (aOR, 1.005; 95% CIs, 1.002\u20131.007) as well as MP-specific IgM titer (aOR, 1.309; 95% CIs, 1.095\u20131.564) were associated with no response or progression of MP pneumonia. The area under the curve for the prediction of no or poor response in MP pneumonia using pleural effusion, respiratory virus co-infection, LDH levels, and MP-specific IgM titer at the time of admission was 0.8547. This study identified the predictive factors of responses to treatment of MP pneumonia in children, which would be helpful in establishing a therapeutic plan and predicting the clinical course of MP pneumonia in children.<\/jats:p>","DOI":"10.3390\/jcm10061154","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T13:27:20Z","timestamp":1615382840000},"page":"1154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Predictive Factors of the Responses to Treatment of Mycoplasma pneumoniae Pneumonia"],"prefix":"10.3390","volume":"10","author":[{"given":"Eun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-4810-9","article-title":"Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3345\/kjp.2017.60.5.151","article-title":"Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children","volume":"60","author":"Lee","year":"2017","journal-title":"Korean J. Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.14740\/jocmr3421w","article-title":"Mycoplasma pneumoniae: A Potentially Severe Infection","volume":"10","author":"Bajantri","year":"2018","journal-title":"J. Clin. Med. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37037","DOI":"10.1038\/srep37037","article-title":"Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ppul.24327","article-title":"Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children","volume":"54","author":"Yan","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children","volume":"57","author":"Tamura","year":"2008","journal-title":"J. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12934","DOI":"10.1038\/s41598-017-13292-5","article-title":"Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhou, Y., Li, S., Yang, D., Wu, X., and Chen, Z. (2016). The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156465"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106209","DOI":"10.1016\/j.rmed.2020.106209","article-title":"Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance","volume":"175","author":"Lee","year":"2020","journal-title":"Respir. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-019-0105-2","article-title":"High co-expression of TNF-\u03b1 and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia","volume":"25","author":"Li","year":"2019","journal-title":"Mol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","article-title":"Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children","volume":"6","author":"You","year":"2014","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tsai, T.-A., Tsai, C.-K., Kuo, K.-C., and Yu, H.-R. (2020). Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J. Microbiol. Immunol. Infect.","DOI":"10.1016\/j.jmii.2020.10.002"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105921","DOI":"10.1016\/j.mimet.2020.105921","article-title":"Comparison of a novel chemiluminescence immunoassay with the passive agglutination method for the diagnosis of Mycoplasma pneumoniae infection in children","volume":"173","author":"He","year":"2020","journal-title":"J. Microbiol. Methods"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2147\/TCRM.S159227","article-title":"Comparison of chemiluminescence immunoassay, enzyme-linked immunosorbent assay and passive agglutination for diagnosis of Mycoplasma pneumoniae infection","volume":"14","author":"Chen","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yoon, I.A., Hong, K.B., Lee, H.J., Yun, K.W., Park, J.Y., Choi, Y.H., Kim, W.S., Lee, H., Eun, B.W., and Ahn, Y.M. (2017). Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2500-z"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Cho, Y.J., Han, M.S., Kim, W.S., Choi, E.H., Choi, Y.H., Yun, K.W., Lee, S., Cheon, J.-E., Kim, I.-O., and Lee, H.J. (2019). Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219463"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/adc.78.1.67","article-title":"Analysis of mycoplasmal pleural effusion by the polymerase chain reaction","volume":"78","author":"Narita","year":"1998","journal-title":"Arch. Dis. Child."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4426-0","article-title":"Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4187\/respcare.03920","article-title":"Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children","volume":"60","author":"Lu","year":"2015","journal-title":"Respir. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-019-1152-5","article-title":"Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: A case control study","volume":"20","author":"Choi","year":"2019","journal-title":"Respir. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jiac.2014.01.001","article-title":"Management of refractory Mycoplasma pneumoniae pneumonia: Utility of measuring serum lactate dehydrogenase level","volume":"20","author":"Inamura","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e22431","DOI":"10.1002\/jcla.22431","article-title":"Evaluation of the Virclia\u00ae automated chemiluminescent immunoassay system for diagnosing pneumonia caused byMycoplasma pneumoniae","volume":"32","author":"Berruezo","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmii.2018.09.009","article-title":"Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and\/or delayed treatment matter?","volume":"52","author":"Yang","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-019-0990-8","article-title":"Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: Meta-analysis of randomized controlled trials","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Pulm. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"39929","DOI":"10.1038\/srep39929","article-title":"The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children","volume":"6","author":"Yan","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/6\/1154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:35:53Z","timestamp":1760160953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/6\/1154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["jcm10061154"],"URL":"https:\/\/doi.org\/10.3390\/jcm10061154","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]}}}